|
Mini-Plenary Sessions
WEDNESDAY, OCTOBER 20
Wednesday morning's program offers
six concurrent mini-plenary sessions,
each focusing on issues important to
an industry sector or an aspect of
licensing practice applicable to all
industries. These mini-plenary sessions
are open to all registrants. Please join
the mini-plenary of your choice.
9:00 a.m.-12:00 p.m. All Sessions
10:15-10:45 a.m. Coffee Break
HEALTHCARE
Feeding the Pipeline V:
Dealing for Mutualism
Feeding the Pipeline presentations
began in 2000 to document the limitations
of big pharma's intense stampede
for an incredibly shrinking number of
late-stage product opportunities. This
year's presentation will consider the
role of L&BD executives within the
current context of unprecedented
challenges to the industry.
Feeding the Pipeline V will consider
(1) current conditions and trends within
the biopharmaceutical industry complex;
(2) challenges and opportunities
presented by instabilities within the
complex, and by trends and realities
such as pharma's gravitation into specialty
areas and biotech's lead product
dependence; and (3) the implications
for remodeling and deal-making within
and among both sectors.
Speaker:
Edward C. Saltzman
President, Defined Health
Patent Issues that Arise in
Alliances Designed to Bring
Drugs to the Developing World
In 1955, when Dr. Jonas Salk was
asked who held the patent rights to
his polio vaccine, he said, "The people.
To patent the vaccine would be like
patenting the sun." Yet without mechanisms to protect intellectual
property and ensure a return
on investment, private companies are
unlikely to invest the enormous sums
of money needed to develop and manufacture
vaccines such as an AIDS
vaccine. This economic reality begs
the question of how such vaccines get
quickly to those who need it most, in
the developing countries least able
to pay for it.
Several new initiatives, funded by
the Gates Foundation, the Rockefeller
Foundation, the World Bank, and
others, have crafted creative arrangements
with industrial partners to fund
research and development of AIDS
vaccines and license the resulting technology
in developing countries. These
contracts provide significant funding,
but stipulate that resulting products
must be made available in developing
countries rapidly after licensure, at
reasonable prices and in sufficient
quantities. A panel of industry and
Foundation leaders will discuss the
challenges of these agreements, the
terms and conditions and negotiations,
and how well the alliances are
working.
Moderator:
Kim Rosenfield
Of Counsel, Mintz, Levin, Cohn, Ferris,
Glovsky & Popeo, P.C.
Speakers:
Wayne KoffPh.D.
Senior Vice President, Vaccine Research, International
AIDS Vaccine Initiative
Dennis Panicali
Chief Scientific Officer,
Therion Biologics
Eric H. Iverson
Associates General Counsel, Bill & Melinda Gates Foundation
Hannah Kettler, Ph.D.
Program Officer, Global Health Program, Bill & Melinda Gates Foundation
ENERGY, CHEMICALS, PETROCHEMICALS,
POLYMERS AND ASSOCIATED INDUSTRIES
Know How and Materials: Ê4 Perspectives on Licensing/Transaction Value
Acquiring rights under patents and copyrights is just the tip of the iceberg in so many deals. ÊAccess to know how and exemplary materials can become an unexpected bottleneck in successful licensing and business transactions in our sectors. ÊEffective transfer of key know how, trade secrets, and the practical side of valuable business processes can really accelerate cash flows. How to make it happen? ÊThe Panel will discuss 4 diverse perspectives on the criticality of know how and materials access in licensing and other transactions: ÊLegal, University, M&A, and Corporate, all important in today's world of alliances and cross-border deals. Learn about the issues pre- and post-close , and take away a sample agreement that captures the key concepts.
Moderator:
Phil Barnett, Moderator (E104 Chair-elect)
Director, Intellectual Asset
Management, Financial Advisory
Services, PricewaterhouseCoopers LLP
Speakers:
Christopher A. Bloom
Partner
Bell Boyd & Lloyd
Michael J. Martin
Executive Vice President
Virginia Tech Intellectual Properties
Craig Heim
Vice President
Grace Matthews, Inc.
Jay Simon
Attorney, JS Consulting
FINANCIAL MARKETS
IP Monetization: Approaches
for Single Assets and Asset
Portfolios
Capital markets have been consistently
unfriendly to healthcare companies
over the past 20 years. Long droughts
of available public capital are followed
by short windows in the public equity
markets, typically with bubble valuations.
Although "private equity/venture
capital" should be taking a longer term
view, these sources of capital are also
linked inextricably to the public equity
markets. These same trends apply to
high tech markets, although with
somewhat more consistency in availability
of capital.
Over the past several years, intellectual
property magazines and conferences
have sprung up touting the
arrival of a panacea-IP securitization.
What is required for an IP securitization
and what is possible as an outcome
are largely misunderstood. These
misperceptions are frequently propagated
by theoretical practitioners, advisors
and other intermediaries.
This Mini-Plenary will address the
practical options available to owners of
single IP asset and IP asset portfolios.
It will include discussions and descriptions
of transactions that have provided
approximately $1 billion of capital to
owners of life science intellectual property
and related assets over the past 5
years. The Mini-Plenary will also help
to describe more clearly the circumstances
under which securitizations
are feasible.
Speakers:
Lionel Leventhal
Partner, Paul Capital Partners
Chris Haase
Associate Vice President, Ventures,
BTG International Inc.
Ira Wagner
Senior Managing Director,
Bear Stearns & Co., Inc.
HIGH TECHNOLOGY
What's Next with Open Source
and How Do We Get There?
Licensing professionals, enterprises,
established software companies, universities,
governments and the current
Open Source community will highlight
their perspectives on business, legal,
technical, operational, social, and
cultural aspects. All the panelists have
extensive background and insight into
the practical interplay of technology,
business and society, both inside and
outside the Open Source arena. This
range and diversity provide excellent
insight into both the visions and
the paths.
Moderator:
Mike Milinkovich
Executive Director, Eclipse Foundation
Speakers:
Scott Handy
Vice President, Worldwide Linux
Strategy and Market Development,
IBM Corporation
Doug Levin
Founder, President and Chief
Executive Officer, Blackduck
Software Inc.
Don Shafer
Chief Technology Officer,
Athens Group, Inc.
John Clippinger
Assistant Professor,
Harvard Law School
Jim Harvey
Partner, Alston & Bird
James DeGraw
Partner, Ropes & Gray
INDUSTRY/UNIVERSITY AND
GOVERNMENT LABORATORY
TRANSACTIONS
Government Technology
Transfer: Perspectives from
the U.S. and Canada
Ever wondered what the "secret" is
to engaging the federal government in
successful technology transfer relationships?
Are you confused by all the different
contract mechanisms, terms and
conditions, and operating procedures
employed by each government agency?
In this mini-plenary, you will hear from
individuals representing different agencies
from both the U.S. and Canada.
Each speaker will explain how their
programs work, and what you need to
do in order to build successful technology
partnerships.
Moderator:
Mark S. Allen
Business Development Manager,
Sandia National Laboratories
Speakers:
Richard J. Brenner
Deputy Assistant Administrator, Office
of Technology Transfer, USDA
Agricultural Research Service
Kevin A. McMahon
Manager, Licensing and IP
Management, Sandia National
Laboratories
Cynthia E. Gonsalves
Manager, Technology Transfer Program,
U.S. Department of Defense
Steven Ferguson
Division Director, Office of
Technology Transfer, U.S. National
Institutes of Health
Jeet Hothi
Manager, Technology Transfer Office,
Communications Research Centre
Canada, Communications Canada
Pierre Meloche
Industrial Technology Advisor, National
Research Council Canada
TRANSPORTATION AND MECHATRONICS
Stories from the Front:
Technology Branding,
Marketing, and Growing
a Successful Licensing
Activity
Many technologies require closer interaction
between licensor and licensee
than a simple arms-length licensing
arrangement. This mini plenary session
will focus on company-to-company
interaction in the areas of how to market,
brand, and manage the business
resulting from technology licensing.
The practical issues of what and how
to market and brand technology as well
as what and how to avoid known
problems will be addressed by a variety
of area experts. Software, business
methods, creating and leveraging brand
equity, and trademark issues will be
discussed in the context of licensing.
Moderators:
Alfred Zaher
Partner, Woodcock Washburn
Jeffrey Solash
Licensing Executive, Delphi
Speakers:
Charley Eberhard
Program Manager, Procter & Gamble
William Elkington
Senior Director, Rockwell Collins
Mark Guetilich
Associate Counsel, Microsoft
Corporation
Peter Makula
Director, Tipping Sprung
Dale New
Senior Vice President, DePersico Creative
Group
David Prawel
Principal, Longview Partners
Martyn Tipping
President and Chairman,
Tipping Sprung LLC
George Weldon
Associate General Counsel, H.D. Lee
|
